🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Recently, we celebrated Robyn Bilmes & Riemke R. Van Dijkhuizen being recognized as Luminaries, and Shawn Keogan as a Rising Star at HBAnet's Woman of the Year event! Thank you for your leadership and impact. #HBAWOTY2025

What makes a difference in a cancer journey? Our patient advisors and patient advocates say: self-advocacy. This week on #AntibodyHour 🕙, hear from Keith, Portia Badham, and Stephanie Lieber on why it’s not just empowering—it’s essential. #PatientAdvocacy #Innovation

We’re looking forward to #EHA2025, where we will be presenting 14 abstracts that showcase our latest research evaluating our investigational medicine in #BloodCancer, furthering our goal of improving the lives of patients. Learn more: gmab.ly/N5Jh50VTwN9

This #OncologyNursingMonth, Genmab celebrates the impact of oncology nurses everywhere. During this edition of #AntibodyHour 🕙, we spotlight our colleague Emily Spencer, RN, Sr. Manager, Patient Engagement Liaison, as she shares how her experience as a former oncology nurse

We’re looking forward to presenting our latest data in gynecologic oncology and hematology at the ASCO #ASCO2025 Annual Meeting. At Genmab, we’re committed to advancing #innovative antibody therapies for cancer patients. Learn more: gmab.ly/1WwI50VXPgX.

At Genmab, we recognize that each patient’s journey is unique, and a diagnosis can be life-altering—not just for patients but for families and friends as well. During this #AntibodyHour 🕙 episode, Keith shares his experience with cancer, challenging misconceptions and

We will be in Chicago for the ASCO Annual Meeting. Stop by booth 27115 to connect with our team to learn how we’re advancing antibody science with the purpose of shaping what’s next in oncology. Learn more at: bit.ly/4l2JfC2. #ASCO2025

At Genmab, our purpose is driven by the voices of patients. Thank you to the incredible leaders from patient advocacy organizations and professional societies who met with us at ASCO 2025. Your perspectives continue to shape how we innovate antibody medicines and support the

Our data presentation at ASCO #ASCO2025 Annual Meeting is a testament to our work toward advancing #AntibodyScience to address the unmet need in gynecologic oncology. Read more: gmab.ly/UlzU50W2Rt2.

We’re headed to #BIO2025 and ready to connect, collaborate, and drive antibody innovation forward. For more information, please contact [email protected]. #BIOInternationalConvention #Biotech

On this #NationalCancerSurvivorsDay we’re spotlighting the voices that matter most — patients. Hear from Keith & Portia as they share their powerful journeys and survivorship. #PatientFirst #Innovation

Thank you to everyone who connected with us at the ASCO 2025 meeting! We're energized by the conversations, inspired by the community, and proud to share our purpose in advancing cancer care. #ASCO2025 #Oncology #Innovation

We’re excited to share the latest from our #hematology research at #EHA25! Join us at the European Hematology Association’s Congress to explore how we’re turning science into medicine. Visit us at location G.03 and learn more here: bit.ly/43lvdBO. #Oncology #Biotech

#InvestorUpdate: We are excited to participate in a fireside chat at the Goldman Sachs 46th Annual Global Healthcare Conference. Click here to learn more: lnkd.in/g2Ufh7Za.

At #EHA2025, we are excited to present new clinical data for #BloodCancer. Swipe to learn more about the subtypes of non-Hodgkin #lymphoma (NHL) – a diverse group of blood cancers that arise from lymphocytes, a type of white blood cell.

Breaking News: We shared new data evaluating our investigational antibody medicine in patients with relapsed or refractory #DLBCL at #EHA2025, in partnership with @AbbVie. Read more: gmab.ly/9zmm50Wa4xn

Leaving #EHA2025 inspired! Grateful to the European Hematology Association community for a powerful few days of science, collaboration, and innovation in hematology. A fantastic opportunity to connect, learn, and advance care for patients worldwide. #Innovation #Hematology

We’re looking forward to #18ICML, where we will be presenting 27 abstracts that showcase our latest research in #BloodCancer.

We believe that transforming the lives of patients starts with empowering our people. This week on #AntibodyHour 🕙, hear from our colleagues Ewan Robson & Francis Blokzijl who share how our open culture drives collaboration to continue advancing innovation in antibody